相关实验视频

Updated: Jun 7, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

针对头癌的精准医学进展

Sanaz Vakili¹, Amir Barzegar Behrooz¹, Rachel Whichelo^1,2

¹Department of Human Anatomy and Cell Science, University of Manitoba College of Medicine, Winnipeg, MB R3E 0J9, Canada.

|November 9, 2024

概括

这项研究分析了头癌 (HNC) 的生物标志物,识别了关键基因和参与其发展和进展的微RNA (miRNA). 这些发现突出了个性化治疗的潜力,并改善了HNC护理中的患者结果.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

头癌 (HNC) 是一种普遍存在的恶性瘤,具有显著的分子多样性.
了解HNC生物标志物对于诊断,预后和向治疗至关重要.
现有的研究需要对与HNC相关的生物标志物进行全面的比较分析.

研究的目的:

对头癌 (HNC) 的生物标志物进行全面的比较分析.
阐明关键蛋白质,基因和微RNAs (miRNAs) 在HNC瘤发生和进展中的作用.
确定这些生物标志物对个性化HNC护理的诊断,预后和治疗相关性.

主要方法:

关键基因和与HNC相关的microRNAs (miRNAs) 的生物信息验证.
在HNC中对蛋白质和基因表达模式的比较分析.
在HNC瘤发生过程中生物标志物的作用的文献综述和数据综合.

主要成果:

确定了关键基因 (例如,AURKA,HMGA2,MMP1,PLAU,SERPINE1) 和oncomiRs (例如,hsa-miR-21-5p,hsa-miR-31-5p) 驱动HNC的进展.
突出抑制瘤的miRNAs (例如,hsa-miR-375,hsa-miR-145-5p) 抑制了HNC.
揭示了hsa-miR-155-3p和RAI14,S1PR5,OSBPL10,METTL6等基因在HNC存活中的预后潜力.

结论:

包括特定基因和miRNA在内的生物标志物在HNC中具有显著的诊断和预后价值.
精准医学方法整合了新型治疗方法,人工智能可以优化HNC患者的治疗结果.
对这些生物标志物的进一步研究对于推进个性化HNC治疗策略至关重要.

关键词:

生物标志物生物标志物遗传变化遗传变化头部和部癌症头部和部癌症精准医学是一门精准医学.有针对性的治疗.

更多相关视频

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...